1Franco E L, Duarte-Franco E, Ferenczy A, et al. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection [J]. CMAJ, 2001,164 (7):1017 - 1025.
2Xu J, Attisano L. Mutations in tumor suppressors Smad2 and Smad4 inactivate transforming growth factor β signaling by targeting Smads to the ubiquitin-proteasome pathway [J]. Proc Natl Acad Sci USA, 2000,97 : 4820-4825.
3Prestrzeniewicz-Ulanska D, Brys M, Semczuk A, et al. Expression and intracellular localization of Smad proteins in human endometrial cancer [J]. Oncol Rep, 2003,10(5): 1539-1544.
4Korchynskyi O, Landstrom M, Stoika R, et al. Expression of Smad proteins in human colorectal cancer [J]. Int J Cancer, 1999,82(2) : 197-202.
5Funaba M, Mathews L S. Identification and characterization of constitutively active Smad2 mutants: evaluation of formation of Smad complex and subcellular distribution [J]. Mol Endocrinol, 2000, 14(10): 1583-1591.
6Lee D K, Kim B C, Kim I Y, et al. The human papillomavirus E7 oncoprotein inhibits transforming growth factor-β signaling by blocking binding of the Smad complex to its target sequence [J]. J Biol Chem, 2002,277 (41) : 38557- 38564.
